肝癌姑息切除术后辅加肝动脉栓塞化疗的疗效

原发性肝癌容易发生肝内转移，所以能得到根治性切除术的病例不多。而对于姑息性切除的病人其疗效不佳，中位生存期也只有６个月左右。本文报道５５例仅作姑息性切除和３９例作姑息性切除后３至４周辅加栓塞化疗的原发性肝癌病人的疗效。随访结果表明：其术后１、２、３、４年生存率在作姑息性切除的病人和作姑息性切除后３至４周辅加栓塞化疗组病人中，分别为８８．０％、３５．８％、０％、０％和８６．０％、６８．４％、５１．８％、３８．７％（Ｐ＞０．０１），其中位生存期分别为７个月和１６个月。

CHEMOEMBOLIZATION FOR PRIMARY LIVER CANCER AFTER PALLIATIVE HEPATECTOMY

Due to the high intrahepatic metastatic rate of primary liver cancer,theradical hepatic resection is limited. The result of palliative hepatic resection is not so satisfactoryand the mediam survival time were only about 6 months usually.This papaer reported the resultsof 55 cases with primary liver cancer after palliative hepatic resection and 39 cases after palliativehepatic resection combimed with chemoemboliZation 3 to 4 weeks post-operation.The 1-,2-,3-,4-years Survival rates of the patiens who underwent palliative hepatic resection alone were88.0%,35.8%,0%,0%respectively,while in the patients who treared by combination Withchemoembolization were 86.0%, 68.4%, 51.8%and3.7%respectively.The median survivaltime of them were 7 and 16 months respectively.